Holderness Investments CO Dexcom Inc Transaction History

Holderness Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $33,519 - $65,514	-493 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $1,881 - $2,604	-20 Reduced 3.9%	493 $252,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $213 - $286	-2 Reduced 0.39%	513 $281,000
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $41,709 - $55,583	515 New	515 $220,000

1,113

365M

4.1M

3.65M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

Stay updated on Holderness Investments CO with notifications on news.